The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
IPRS leads from the front as India Records 357% Growth in Royalty Collections
Mumbai, 29th May 2025– The Indian Performing Right Society Ltd. (IPRS) welcomes the release of the CISAC Annual Report 2025, which showcases India’s strong…
MGM Healthcare Strengthens Preventive Wellness Through Trackathon 2026
Chennai, Feb 10: Reinforcing its commitment to preventive wellness and community fitness, MGM Healthcare successfully powered the latest edition of the MGM Healthcare Trackathon, hosted by Chennai Runners at…
IIM Udaipur’s Consumer Culture Lab Shares the Country’s First-Ever Digital Research on India’s Rural & Regional Heartlands
19th February 2023, Udaipur: The Consumer Culture Lab of IIM Udaipur, the only such Lab of its kind in any…